KONTA CHINA (1312.HK)
Market: HKEX |
Currency: HKD
Address: Sun Hung Kai Centre
Kontafarma China Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally. It operates in Pharmaceutical Business and Fitness Business segments. The company offers chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers; operates in the franchise business; and provides consultation services for fitness and health activities. It also researches and develops medical products; and offers corporate advisory services. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Show more
📈 KONTA CHINA Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
10-25%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for KONTA CHINA
Date | Reported EPS |
---|
2025-03-25 | - |
📰 Related News & Research
No related articles found for "konta china".